This inventor holds 1 USPTO granted patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Frank-Gerhard BÖβ: Innovator in Medicinal Chemistry
Introduction
Frank-Gerhard BÖβ is a notable inventor based in Sunninghill, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on amides of acetic and propionic acids. His research focuses on the development of novel compounds that have potential applications in the treatment and prevention of various diseases.
Latest Patents
Frank-Gerhard BÖβ holds a patent for "Amides of acetic and propionic acids." This invention relates to the creation of new amides, along with methods for their production. These compounds are designed for use in the development of medicaments aimed at improving perception, concentration, learning ability, and memory. His work in this area highlights the importance of chemical innovation in enhancing cognitive functions and overall health.
Career Highlights
BÖβ is associated with Bayer Intellectual Property GmbH, where he continues to advance his research and development efforts. His role at Bayer allows him to collaborate with other experts in the field and contribute to the company's mission of improving health through innovative solutions.
Collaborations
Frank-Gerhard BÖβ has worked alongside notable colleagues such as Joachim Luithle and Christina Erb. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries in medicinal chemistry.
Conclusion
Frank-Gerhard BÖβ is a distinguished inventor whose work on amides of acetic and propionic acids exemplifies the intersection of chemistry and medicine. His contributions are paving the way for advancements in treatments that can significantly improve cognitive functions and health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
